Ahren Innovation Capital — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Bicycle TherapeuticsNASDAQ: BCYCMay 2024

Biotech company that reached IPO

BiotechCambridge

KEVIN LEE(Executive Officer, Director)FELIX J. BAKER(Director)RICHARD N. KENDER(Director)GREGORY WINTER(Director)STEPHEN SANDS(Director)NIGEL CROCKETT(Executive Officer)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.